BIOMAT Database Logo BIOMAT Database Logo

[Treatment of pulmonary thromboembolism with low molecular weight heparin]. 1995

E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez

UI MeSH Term Description Entries
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015912 Thrombolytic Therapy Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts. Fibrinolytic Therapy,Thrombolysis, Therapeutic,Therapeutic Thrombolysis,Therapy, Fibrinolytic,Therapy, Thrombolytic,Fibrinolytic Therapies,Therapeutic Thrombolyses,Therapies, Fibrinolytic,Therapies, Thrombolytic,Thrombolyses, Therapeutic,Thrombolytic Therapies

Related Publications

E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin.
January 1995, Journal of thrombosis and thrombolysis,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Low molecular weight heparin treatment of venous thromboembolism.
January 1994, Progress in cardiovascular diseases,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism.
January 2002, Respiration; international review of thoracic diseases,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
[Low-molecular-weight heparin for the treatment of acute pulmonary thromboembolism. Comparison with unfractionated intravenous heparin].
April 2005, Anales de medicina interna (Madrid, Spain : 1984),
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
[Treatment of venous thromboembolism in pregnancy with low molecular weight heparin].
August 2000, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Long-term treatment of venous thromboembolism with low-molecular-weight heparin.
July 2000, Current opinion in pulmonary medicine,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
[Efficacy and safety of low molecular weight heparin in the treatment of pulmonary thromboembolism].
June 1999, Medicina clinica,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Heparin and low-molecular-weight heparin in the treatment of venous thromboembolism.
September 1998, Bailliere's clinical haematology,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Treatment of venous thromboembolism using only low-molecular-weight heparin?
August 2001, The American journal of medicine,
E Montero Ruiz, and F Lucena Marotta, and F Gutiérrez Marcos, and J López Alvarez
Low-molecular-weight heparin in the treatment of venous thromboembolism.
January 2000, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!